A SELECTIVE ALTERNATIVE PATHWAY COMPLEMENT INHIBITOR FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Hagen Sülzen.

SASDV84 – SH-01 in complex with Fab 3E12

SH-01
Fab 3E12
MWexperimental 91 kDa
MWexpected 91 kDa
VPorod 124 nm3
log I(s) 4.98×103 4.98×102 4.98×101 4.98×100
SH-01 Fab 3E12 small angle scattering data  s, nm-1
ln I(s)
SH-01 Fab 3E12 Guinier plot ln 4.98×103 Rg: 3.8 nm 0 (3.8 nm)-2 s2
(sRg)2I(s)/I(0)
SH-01 Fab 3E12 Kratky plot 1.104 0 3 sRg
p(r)
SH-01 Fab 3E12 pair distance distribution function Rg: 4.0 nm 0 Dmax: 14 nm

Data validation


Fits and models


log I(s)
 s, nm-1
SH-01 Fab 3E12 DAMMIN model

Synchrotron SAXS data from solutions of SH-01 in complex with Fab 3E12 in 20 mM HEPES, 150 mM NaCl, 3% glycerol, pH 7.5 were collected on the EMBL P12 beam line at PETRA III (DESY; Hamburg, Germany) using a Pilatus 6M detector at a sample-detector distance of 3 m and at a wavelength of λ = 0.124 nm (I(s) vs s, where s = 4πsinθ/λ, and 2θ is the scattering angle). In-line size-exclusion chromatography (SEC) SAS was employed. The SEC parameters were as follows: A 50.00 μl sample at 7.2 mg/ml was injected at a 0.30 ml/min flow rate onto a Cytiva Superdex 200 Increase 5/150 column at 20°C. 1800 successive 0.500 second frames were collected throughout the entire SEC column elution; 106 frames were measured across the sample elution peak and used for averaging. The data were normalized to the intensity of the transmitted beam and radially averaged; the scattering of the solvent-blank was subtracted.

SH-01
Mol. type   Protein
Olig. state   Monomer
Mon. MW   40.8 kDa
Sequence   FASTA
 
Fab 3E12
Mol. type   Protein
Organism   Mus musculus
Olig. state   Monomer
Mon. MW   50 kDa
Sequence   FASTA